Yashpal Agrawal, M.B., B.S., Ph.D.

Anatomic Pathology and Clinical Pathology
Yashpal Agrawal

Dr. Yash Pal Agrawal, M.B.,B.S., PhD is  Professor of Clinical Pathology and Laboratory Medicine at Weill Medical College. He is the Director of the Central Laboratory and Director of Point of Care Services at New York Presbyterian Hospital. He is an expert in clinical diagnostic testing and laboratory medicine. Dr. Agrawal is board certified by the American Board of Pathology in Clinical Pathology, and in Clinical Chemistry by the Medical Board of Finland. Dr. Agrawal is the Chair of the College of American Pathologists (CAP) Resource Committees on Toxicology and Therapeutic Drug Monitoring. He has been a past member of the College of American Pathologists working groups on Pharmacogenetics and involved in the design of teaching modules and as a reviewer for Pharmacogenomics modules. He is a past member of the Special Chemistry committee. He also serves as an ad hoc member of the Clinical Laboratory Standards Institution (CLSI) working groups. He has published extensively in laboratory medicine and is also a contributing author to multiple text books in laboratory medicine.

Dr. Agrawal completed his medical training in his native India and completed a Ph.D in reproductive biology at the University of Kuopio, Finland in 1987. Subsequently he completed 4 years of residency training in clinical chemistry (laboratory medicine) at the Kuopio University Hospital, Finland. At Kuopio he served as the Assistant Chief of Laboratory Medicine (Clinical Chemistry). Dr.Agrawal did his post-doctoral training at the University of California, San Diego in the field of Gene Therapy and Hematopoietic Stem Cells. Subsequently, he immigrated to the United States and trained in Anatomic Pathology at Yale University and in Clinical Pathology at Massachusetts General Hospital, Harvard University. He has served as a faculty member and attending physician at the University of Iowa Hospitals and Clinics and as Director of Chemistry at the Iowa City VA Medical Center and also as Regional Commissioner for Region 7 (seven midwestern states) in the National Veterans Administration Health System. He currently serves at the New York Presbyterian Hospital-Cornell Campus and at the Weill Medical College.


Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please feel free to contact this physician or this physician's practice as they may have individual contracts not included on this site.

  • AETNA [Medicare]
  • Aetna - Weill Cornell [POS]
  • Affinity Essential
  • Affinity Health Plan
  • Blue Priority Network
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield [Pathway X]
  • Empire Blue Cross/Blue Shield [Pathway X Enhanced]
  • Empire Blue Cross/Blue Shield [PPO]
  • Empire Blue Cross/Blue Shield [EPO]
  • Empire Blue Cross/Blue Shield [HMO]
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Fidelis Care
  • GHI [CBP]
  • Health First
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP)
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Plus - Amerigroup [CHP]
  • Health Plus - Amerigroup
  • Health Republic
  • Medicare [Medicare]
  • Oscar
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Freedom]
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care
  • United Health Care [Medicare]
  • United Health Care [Community Plan]
  • VNSNY CHOICE Medicare [Medicare]
  • VNSNY CHOICE Medicare [HMO]



1.   Vanha-Perttula T, Agrawal Y, Jauhianen A. Aminopeptidase A in reproductive organs of the male rat: evidence for high activity in the posterior lobe of prostate. Int J Androl 7: 419-430, 1984.

2.   Agrawal Y, Vanha-Perttula T.Variable distribution of aminopeptidase A in male reproductive organs of mammals. Int J Androl 8: 243-256, 1985.

3.   Agrawal Y, Vanha-Perttula T. Studies on the multiple forms of aminopeptidase A in bovine seminal vesicle secretion. Int J Biochem 18: 465-471, 1986.

4.   Agrawal Y, Vanha-Perttula T. Alanyl aminopeptidase of bovine seminal vesicle secretion. Int J Biochem 18: 725-729, 1986.

5.   Agrawal Y, Vanha-Perttula T. Dipeptidyl peptidases in bovine reproductive organs and secretions. Int J Androl 9: 435-452, 1986.

6.   Agrawal Y, Vanha-Perttula T. The effect of secretory particles in bovine seminal vesicle secretion on sperm motility and acrosome reaction. J Reprod Fert 79: 409-419, 1987.

7.   Agrawal Y. Distribution, secretion and properties of some exopeptidases in the male reproductive organs. Publ.Univ.Kuopio, Medicine 4:1-72, 1987.

8.   Agrawal Y, Vanha-Perttula T. Electron microscopic study of the secretion process in bovine reproductive organs. J Androl 9:307-316, 1988.

9.   Agrawal Y, Vanha-Perttula T. Glutathione, L-Glutamic acid and gamma-Glutamyl transpeptidase in the bull reproductive tissues. Int J Androl 11: 125-131, 1988.

10.   Agrawal YP, Vanha-Perttula T. ??-Glutamyl transpeptidase, glutathione and L-Glutamic acid in the rat epididymis during postnatal development. Biol Reprod 38:996-1000, 1988.

11.   Agrawal Y, Vanha-Perttula T: Biochemical and histochemical studies on Dipeptidyl Peptidases I-IV in the bovine reproductive organs. Biol Zent biol 107:211-214, 1988

12.   Agrawal YP, Vanha-Perttula T. ??-Glutamyl transpeptidase in murine epididymis: distribution and response to acivicin. J Reprod Fert 86:185-193, 1989.

13.   Agrawal YP, Vanha-Perttula, T. ??-Glutamyl transpeptidase in rat epididymis: Effects of castration, hemicastration and efferent duct ligation. Int J Androl 12:321-328, 1989.

14.   Vanha-Perttula T, Agrawal YP. The role of enzymes in post-testicular maturation of spermatozoa. Molecular Andrology 2:1-34, 1989.

15.   Räsänen M, Saaranen M, Penttilä I, Agrawal YP. Flow cytometry for measurement of antibodies to spermatozoa in subfertile men. Lancet 336:887-888, 1990.

16.   Agrawal YP, Mahlamäki E: Terminaalinen deoksinukleotidyylitransferaasi (TdT) värjäyksenkäyttö hematologiassa. Kliin Lab 3:65-67, 1991 (Finnish).

17.   Räsänen ML, Hovatta OL, Penttilä IM, Agrawal YP. Detection and quantitation of sperm bound antibodies by flow cytometry of human semen. J Androl 13:55-64, 1992.

18.   Agrawal YP, Hämälainen E, Mahlamäki EK, Aho H, Nousiainen T, Lahtinen R, Penttilä IM. Comparison of poly- and monoclonal antibodies for determination of B-cell clonal excess in a routine clinical laboratory. Eur J Haematol 48:49-55, 1992.

19.   Agrawal, YP, Penttilä IM. Reticulocyte analysis by flow cytometry using a modified gating procedure. Eur J Haematolol 48: 58-60, 1992.

20.   Agrawal YP: Methodological aspects of the flow cytometric quantitation of cell surface antigens and antibodies. Kliin Lab 10:17-20, 1993.

21.   Räsänen M, Lähteenmäki A-M, Saarikoski S, Agrawal YP. Comparison of flowcytometric measurement of seminal antisperm antibodies with the Mixed Antiglobulin Reaction and the Serum Tray Agglutination Test. Fertil Steril 61:143-150, 1994.

22.   Agrawal RS, Agrawal YP, Mäntyjärvi R. Flow cytometric quantitation of c-myc and p53 proteins in bovine papilloma virus type 1 transformed primary mouse fibroblasts. Cytometry 17:237-245, 1994.

23.   Räsänen M, Saarikoski S, Penttilä I, Agrawal YP. A flow cytometric study on the effect of low dose cyclic prednisolone treatment on sperm-bound antibody levels. Hum Reprod 9:889-893, 1994.

24.   Agrawal YP, Ylikängas P, Parviainen MT, Penttilä IM. Flow cytometric method to measure urea resistant alkaline phosphatase from blood neutrophils for use in the antenatal screening of Down#146;s syndrome Prenat Diagn 14:1141-1149, 1994.

25.   Penttila I, Agrawal YP, Hirvonen K, Hongisto T, Julkunen A, Rantanen T. Modifioitu seerumin troponiini-T:n määritys mikrotiitterilevyllä akuutin sydäninfarktin diagnostiikassa. Kliin Lab2:35-39, 1994 (Finnish).

26.   Räsänen M, Agrawal YP, Saarikoski S. Seminal fluid antisperm antibodies measured by direct flowcytometry do not correlate with those measured by indirect flow cytometry, the indirect immunobead test and the indirect mixed antiglobulin reaction. Fertil Steril 65:170-5, 1996

27.   Räsänen M, Lähteenmäki A, Agrawal YP, Saarikoski S, Hovatta O. A placebo controlled flow cytometric study on the effect of low dose prednisolone treatment on sperm-bound antibody levels. Int J Androl 19:150-154, 1996.

28.   Agrawal YP, Agrawal RS, Sinclair A, Young D, Maruyama M, Levine F, Ho AD. Cell cycle kinetics and VSV-G pseudotyped retrovirus mediated gene transfer in blood derived CD34 cells. Exp Hematol 24:738-747, 1996.

29.   Sinclair AM, Agrawal YP, Elbar EL, Ho AD, Levine F. VSV-G pseudotyped retrovirus efficiently binds and fuses to CD34 and CD34 CD38- hematopoietic progenitor cells. Gene Therapy, 4:918-27,1997.

30.   Agrawal RS, Karhu, K, Kirkinen P, Ylä-Herttuala S, Agrawal YP. Complement and anti-?\-galactosyl natural antibody mediated inactivation of murine retrovirus occurs in adult serum but not in umbilical cord serum. Gene Therapy, 6:146-148, 1999.

31.   Agrawal YP. Platelet Flowcytometry:limitations and possibilities. Klinisk Kemi I Norden 4:92-96, 1999

32.   Agrawal YP, Dzik S. The von Willebrand factor content of factor VIII concentrates. Transfusion 41:153-4, 2001.

33.   Agrawal YP, Freedman M, Szczepiorkowski ZM. The effects of long term transfusion of polymerized bovine hemoglobin in a Jehovah#146;s witness following chemotherapy for myeloid leukemia: a case report. Transfusion, 45:1735-38, 2005.

34.   Agrawal YP. Low dose naltrexone therapy in multiple sclerosis. Med Hypotheses, 64: 721-4, 2005.

35.   Agrawal YP. Possible importance of antibiotics and naltrexone in neurodegenerative disease. Eur J Neurol, 2006, 13:e7.

36.   Lueck N, Agrawal YP. Lack of utility of free light chain specific antibodies in the urine immunofixation test. Clinical Chemistry, 5:906-7, 2006.

37.   Peerschke EIB, Agrawal YP, Alexander CB, Bovill E, Laposata M. Proposed Research Training Guidelines for Residents in Laboratory Medicine. Clin Lab Med 27:241-253, 2007.

38. Mark T, Jayabalan D, Coleman M, Pearse RN, Wang YL, Lent R, Christos PJ, Lee JW, Agrawal YP et al. Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma. Br J Hematol 143 (3):654-60, 2008.

39. Salemi Arash, Agrawal YP. An Assay to Monitor Bivalirudin Levels in Cardiopulmonary Bypass. Ann Thoracic Surgery, 92:332-4, 2011.
40. Carmel Ralph, Agrawal YP. Failures of cobalamin assays in pernicious anemia. New Engl J Med 367:385-386, 2012.
41. Carmel Ralph, Agrawal YP.  Correspondence: More on failures of cobalamin assays in pernicious anemia. New Engl J Med 367:1571, 2012.
42. Agrawal YP, Rennert H. Pharmacogenomic testing of toxicological drugs. Clinics in Laboratory Medicine 32:509-523, 2012.

Honors and Awards

Awarded “Docent in Clinical Chemistry” by the Univ. of Kuopio, Finland   1996

Finnish Advanced Technology Foundation, 1992

Saastamoinen Foundation, Finland, 1994

Finnish Academy, 1994

Instrumentarium Academic Foundation, Finland, 1994

Finnish Academy,1995

Regional Commissioner Award, VA Central Office, 2005

Regional Commissioner Award, VA Central Office, 2006